Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stroke 1Neoplasms 1Myocardial Infarction 1Leiomyoma 1Hemorrhage 1Cardiovascular Diseases 1

Interventions

ulipristal acetate 9Leuprolide 4Uterine Artery Embolization 3ulipristal 2Tranexamic Acid 2Letrozole 2Bupivacaine 2ferrous sulfate 1elagolix 1dienogest 1cetrorelix 1Vitamin B 6 1Uterine Myomectomy 1Sodium Chloride 1Sirolimus 1Saline Solution 1Rocuronium 1Pregabalin 1Oxytocin 1Naproxen 1Misoprostol 1Mifepristone 1Lidocaine 1Ibuprofen 1Goserelin 1Gonadotropin-Releasing Hormone 1DMAC2L protein, human 1Celecoxib 1Anesthetics, Local 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Leiomyoma × Vitamin B 6 × Clear all
NCT02209545 2023-09-07

Misoprostol for Reduction of Blood Loss During Fibroid Surgery

Northwestern University

Phase 4 Terminated
47 enrolled 4 charts

Hemorrhage, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡